BRCA variant classification of ClinVar submitter content from ENIGMA, ARUP laboratories and German cancer consortium compared to MH BRCA® and correlation with response to PARP inhibition in MH GUIDE®. (October 2020) - Stecker, K.; Schmidt-Edelkraut, U.; El Hokayem, J.; Hartenfeller, M.; Diella, F.; Stein, M.; Hermanns, J.; Holtrup, T.; Hettich, S.; Soldatos, T.; Jackson, D.; Brock, S.; et al.